
Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
Here are the top 200 generic drugs by retail dollars in 2007
Here is a listing of the top 200 generic drugs by retail dollars in 2007. The top five include:
Click